Sernova Biotherapeutics (SEOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 10-2020 | 07-2020 | 04-2020 | 01-2020 | 10-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,938 | 72 | 311 | 712 | 1,352 |
| Marketable Securities | N/A | 1,047 | 1,477 | 1,534 | 1,510 |
| Receivables | 377 | 80 | 97 | 277 | 553 |
| TOTAL | $3,426 | $1,255 | $2,121 | $2,970 | $4,001 |
| Non-Current Assets | |||||
| PPE Net | 151 | 159 | 167 | 185 | 189 |
| Intangibles | 682 | 707 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 7 | 27 | 49 | 0 |
| TOTAL | $833 | $872 | $194 | $234 | $189 |
| Total Assets | $4,259 | $2,127 | $2,315 | $3,204 | $4,190 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 653 | 540 | 694 | 309 | 517 |
| TOTAL | $653 | $547 | $722 | $359 | $517 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 523 | 495 | 0 | 0 | 0 |
| TOTAL | $523 | $495 | $N/A | $N/A | $N/A |
| Total Liabilities | $1,176 | $1,043 | $722 | $359 | $517 |
| Shareholders' Equity | |||||
| Common Shares | 33,208 | 30,237 | 30,033 | 31,384 | 31,078 |
| Retained earnings | -35,546 | -34,195 | -33,125 | -33,298 | -31,949 |
| Other shareholders' equity | 1,153 | 933 | 804 | 841 | 832 |
| TOTAL | $3,083 | $1,085 | $1,593 | $2,845 | $3,673 |
| Total Liabilities And Equity | $4,259 | $2,127 | $2,315 | $3,204 | $4,190 |